Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
16.92
+0.65 (4.00%)
At close: Apr 8, 2026, 4:00 PM EDT
17.00
+0.08 (0.47%)
After-hours: Apr 8, 2026, 6:02 PM EDT
Amylyx Pharmaceuticals Market Cap
Amylyx Pharmaceuticals has a market cap or net worth of $1.87 billion as of April 8, 2026. Its market cap has increased by 458.43% in one year.
Market Cap
1.87B
Enterprise Value
1.56B
1-Year Change
458.43%
Ranking
Category
Stock Price
$16.92
Market Cap Chart
Since the IPO on January 7, 2022, Amylyx Pharmaceuticals's market cap has increased from $1.07B to $1.87B, an increase of 74.92%. That is a compound annual growth rate of 14.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 1.87B | 40.98% |
| Dec 31, 2025 | 1.33B | 415.49% |
| Dec 31, 2024 | 257.35M | -74.11% |
| Dec 29, 2023 | 993.86M | -59.40% |
| Dec 30, 2022 | 2.45B | 128.97% |
| Jan 7, 2022 | 1.07B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Supernus Pharmaceuticals | 2.90B |
| Prestige Consumer Healthcare | 2.58B |
| HUTCHMED (China) | 2.49B |
| BioCryst Pharmaceuticals | 2.37B |
| Phibro Animal Health | 2.21B |
| Bausch Health Companies | 2.00B |
| ANI Pharmaceuticals | 1.60B |
| Perrigo Company | 1.47B |